Advanced search
Publication Cover
Current Medical Research and Opinion Volume 37, 2021 - Issue 11
Submit an article Journal homepage
1,551
Views
5
CrossRef citations to date
0
Altmetric
Endocrinology

Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication use

Kelly Adamskia Analysis Group, Inc, Los Angeles, CA, USA
,
Keziah Cookb Analysis Group, Inc, Menlo Park, CA, USACorrespondence[email protected]
,
Deepshekhar Guptab Analysis Group, Inc, Menlo Park, CA, USA
,
Eric Morrisb Analysis Group, Inc, Menlo Park, CA, USA
,
Edward Tuttleb Analysis Group, Inc, Menlo Park, CA, USA
,
Emma Carrc Amryt Pharmaceuticals DAC, Dublin, Ireland
,
Francesco Cremascoc Amryt Pharmaceuticals DAC, Dublin, Ireland
,
Elaine Cochrand National Institute of Diabetes & Digestive & Kidney Diseases, Bethesda, MD, USA
&
Rebecca J. Brownd National Institute of Diabetes & Digestive & Kidney Diseases, Bethesda, MD, USA
 show all
Pages 1881-1889 | Received 07 Jul 2021, Accepted 31 Aug 2021, Published online: 26 Sep 2021

Related Research Data

Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication use
Source: Taylor & Francis
Effects of metreleptin in patients with lipodystrophy with and without baseline concomitant medication use
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.